FDA Approves Mimrylo for Polycythemia Vera

What Is Mimrylo and How Does It Work? The FDA approved Mimrylo (rusfertide) to treat adults with polycythemia vera who have high red blood cell counts. Polycythemia vera is a rare blood cancer that causes… Read more

FDA Approves Mounjaro to Help Lower Heart Attack and Stroke Risk in Adults With Type 2 Diabetes

What Is Mounjaro and Why Does It Matter? The FDA has expanded the use of Mounjaro (tirzepatide). It is now approved to lower the risk of major heart problems, including heart attacks, strokes, and death… Read more

FDA Approves Lisraya, an Oral Pill to Treat Adults With Dermatomyositis

What Is Lisraya and How Does It Work? The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, a rare autoimmune disease. It causes the body’s immune system to attack its own muscles and… Read more

FDA Approves Bixlenvo, a New Daily Pill to Treat HIV

What Is Bixlenvo and Why Does It Matter? The FDA has approved Bixlenvo for adults with HIV-1. It is meant for adults whose virus is already under control with their current HIV treatment. This means… Read more

FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia

What Is Imaavy and How Does It Work? The FDA has approved Imaavy (nipocalimab-aahu) to treat adults and children 12 and older who have warm autoimmune hemolytic anemia (wAIHA). It is for people who are… Read more

FDA Approves Bixlenvo, a New Daily Pill to Treat HIV

The FDA has approved Bixlenvo for adults with HIV-1.It is meant for adults whose virus is already under control with their current HIV treatment. This means their blood test shows low levels of the virus,… Read more

FDA Approves Ziihera Combinations for Advanced Stomach and Esophageal Cancers

What Is Ziihera and How Does It Work? The FDA has approved Ziihera (zanidatamab-hrii) to treat adults with advanced or spreading gastroesophageal adenocarcinoma (GEA). GEA includes cancers of the stomach, the esophagus, and the area… Read more

FDA Approves Uplizna: A Twice-Yearly Targeted Therapy for Adults With Generalized Myasthenia Gravis

Uplizna (inebilizumab-cdon) is a prescription medicine recently approved by the FDA to treat adults with generalized myasthenia gravis (gMG) who test positive for certain antibodies — either anti-acetylcholine receptor (AChR) or anti-muscle specific tyrosine kinase… Read more

Enhertu Plus Pertuzumab: New First-Line Option for Advanced HER2-Positive Metastatic Breast Cancer

Enhertu (fam-trastuzumab deruxtecan-nxki) is a type of targeted cancer treatment called an antibody-drug conjugate.The FDA has approved it in combination with another medicine, pertuzumab, as the first-line treatment for adults with HER2-positive breast cancer that… Read more

FDA Approves Lerochol: A Monthly Injectable Treatment to Reduce High LDL Cholesterol Levels in Adults

Lerochol (lerodalcibep-liga) is a new medicine approved by the FDA to help lower elevated levels of low-density lipoprotein cholesterol (LDL-C), often called “bad cholesterol,” in adults with hypercholesterolemia (high cholesterol levels), including those with a… Read more